“FORMULATION AND CHARACTERIZATION OF NANOSTRUCTURED LIPID CARRIERS OF TOLBUTAMIDE FOR THE TREATMENT OF TYPE II DIABETES”. CAHIERS MAGELLANES-NS 6, no. 2 (November 12, 2024): 7092–7101. Accessed June 13, 2025. http://cahiersmagellanes.com/index.php/CMN/article/view/1040.